Ethical issues of cutting edge biotechnology: Embedded interdisciplinary risk benefit evaluation of first-in-human trials in synthetic biology and nanomedicine Add documents

 
   

MCSS v5.8 PRO. 0.022 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/05/2021